Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy

NCT00295542 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3344

Last updated 2009-04-28

No results posted yet for this study

Summary

The MAPEC study was designed to investigate whether normalizing the circadian blood pressure profile towards a more dipper pattern (increasing the diurnal/nocturnal ratio of blood pressure) by the use of Chronotherapy (that is, taking into account the time of day of administration of antihypertensive medications) reduces cardiovascular risk.

Conditions

Interventions

DEVICE

Ambulatory blood pressure monitoring

Sampling at 20-min intervals from 07:00 to 23:00 hours and at 30-min intervals at night for 48 consecutive hours

PROCEDURE

Chronotherapy, timing of antihypertensive medication

Comparison of effects of awakening versus bedtime dosing

DRUG

ACEI (including spirapril, enalapril, quinapril, lisinopril)

Treatment at awakening versus bedtime

DRUG

ARB (including valsartan, telmisartan, olmesartan)

Treatment at awakening versus bedtime

DRUG

beta blockers (including nebivolol, atenolol, carvedilol)

Treatment at awakening versus bedtime

DRUG

diuretics (torasemide, indapamide, HTCZ) and doxazosin

Treatment at awakening versus bedtime

PROCEDURE

Combination therapy in essential hypertension

Treatment at awakening versus bedtime

Sponsors & Collaborators

  • Hospital Clinico Universitario de Santiago

    collaborator OTHER
  • Ministry of Work and Welfare - Xunta de Galicia

    collaborator OTHER_GOV
  • Ministerio de Educacion y Ciencia, Spain

    collaborator UNKNOWN
  • University of Vigo

    lead OTHER

Principal Investigators

  • Ramon C Hermida, PhD · University of Vigo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-03-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00295542 on ClinicalTrials.gov